Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022

We evaluated neutralising antibody titres against wild type (WT) SARS-CoV-2 and four Omicron variants (BA.1, BA.2, BA.5 and BA.2.75) in fully vaccinated (three doses of Comirnaty vaccine) healthcare workers (HCW) in Israel who had breakthrough BA.1/BA5 infections. Omicron breakthrough infections in...

Descripción completa

Detalles Bibliográficos
Autores principales: Atari, Nofar, Kliker, Limor, Zuckerman, Neta, Elkader, Bayan Abd, Weiss-Ottolenghi, Yael, Mendelson, Ella, Kreiss, Yitshak, Regev-Yochay, Gili, Mandelboim, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635020/
https://www.ncbi.nlm.nih.gov/pubmed/36330820
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.44.2200785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635020/
https://www.ncbi.nlm.nih.gov/pubmed/36330820
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.44.2200785

Ejemplares similares